1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The antiviral nasal spray market is undergoing rapid transformation driven by ongoing public health challenges and emerging innovations. Senior leaders must understand the evolving product landscape, supply chain shifts, and regulatory changes to maintain competitiveness and make informed investment decisions.
Market Snapshot: Antiviral Nasal Spray Market
The antiviral nasal spray market is advancing as companies respond to rising incidences of respiratory viral outbreaks and the growing demand for targeted prophylactic and therapeutic options. Industry momentum is reflected in robust R&D pipelines, active regulatory engagement, and a diversified competitive landscape. The market encompasses key players with established manufacturing footprints, strong partnerships, and a growing emphasis on digital pharmacy channels. Global supply chain complexity and the development of next-generation delivery systems define the current landscape, positioning antiviral nasal sprays as critical tools in public health preparedness and response.
Scope & Segmentation
- Distribution Channels: Hospital pharmacies, general and specialty online retailers, as well as chain and independent retail pharmacies, support widespread product accessibility.
- Prescription Status: Divided into over-the-counter and prescription-only categories, with varying regulatory and reimbursement requirements.
- End Users: Includes primary and specialty clinics, adult and pediatric homecare settings, and both private and public hospitals.
- Age Groups: Segmentation addresses adults aged 18 to 45, those above 45, and pediatric populations from infancy through adolescence and teenage years.
- Regions Covered: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
- Technology Adoption: Includes nanoparticle-based carriers, mucoadhesive polymers, antiviral compounds, and immunostimulatory adjuvants tailored for rapid onset and robust local immune response.
Key Takeaways
- Nasal sprays employing advanced formulation science, such as optimized polymers and nanoparticles, are elevating both retention time and mucosal delivery effectiveness.
- Accelerated regulatory adjustments are enabling faster commercialization pathways, supporting both endemic and emergent viral challenges with more flexible approval routes.
- Pharmaceutical companies and logistics providers are aligning on supply chain resilience, often through localizing production and securing temperature-controlled distribution.
- Strategic alliances between biotech start-ups and established contract manufacturers are facilitating agile adaptation to shifting epidemiological demands and supporting large-scale deployment.
- Market segmentation reveals differentiated end-user needs: adult and pediatric populations, as well as specific care settings, are influencing formulation and dosing approaches.
- Real-time genomic surveillance and molecular analytics are shaping product pipelines and enabling ongoing updates to antiviral agent profiles.
Tariff Impact: 2025 U.S. Adjustments
The 2025 United States tariff changes are prompting manufacturers to reassess sourcing strategies for key raw materials and intermediates. Relocation of formulation activities and increased capital expenditures for regulatory-compliant facilities are reshaping input costs and lead times. Logistics and production partnerships remain vital for maintaining operational continuity under the evolving duty structure.
Methodology & Data Sources
Research leverages a multi-tiered approach, including interviews with market experts, triangulation of peer-reviewed and secondary sources, and validation using production, distribution, and approval data. Recent case studies and iterative panel reviews further ensure accuracy and relevance of market trends.
Why This Report Matters
- Deliver actionable insights to guide product strategy and investment in antiviral nasal spray solutions.
- Support executive decision-making with robust market segmentation, competitive intelligence, and assessment of regulatory and tariff environments.
- Equip stakeholders to anticipate supply chain shifts and respond effectively to emerging public health threats.
Conclusion
The antiviral nasal spray market is defined by continuous innovation and shifting supply chain realities. Organizations that prioritize cross-functional collaboration and regional agility will be best positioned to capitalize on growth and deliver effective viral prevention solutions.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing consumer preference for prophylactic antiviral nasal sprays in respiratory illness prevention
5.2. Advancements in mucoadhesive delivery systems enhancing antiviral retention in nasal mucosa
5.3. Regulatory acceleration for novel broad-spectrum antiviral agents targeting nasal epithelial cells
5.4. Strategic collaborations between biotech startups and pharmaceutical giants driving formulation innovations
5.5. Integration of digital health platforms for remote monitoring of antiviral nasal spray usage and efficacy
5.6. Rising investment in sustainable and ecofriendly packaging solutions for nasal spray products
5.7. Surging demand for over the counter antiviral nasal sprays amid seasonal respiratory virus outbreaks
5.8. Expansion of telemedicine prescriptions influencing distribution channels for antiviral nasal sprays
5.2. Advancements in mucoadhesive delivery systems enhancing antiviral retention in nasal mucosa
5.3. Regulatory acceleration for novel broad-spectrum antiviral agents targeting nasal epithelial cells
5.4. Strategic collaborations between biotech startups and pharmaceutical giants driving formulation innovations
5.5. Integration of digital health platforms for remote monitoring of antiviral nasal spray usage and efficacy
5.6. Rising investment in sustainable and ecofriendly packaging solutions for nasal spray products
5.7. Surging demand for over the counter antiviral nasal sprays amid seasonal respiratory virus outbreaks
5.8. Expansion of telemedicine prescriptions influencing distribution channels for antiviral nasal sprays
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Anti-viral Nasal Spray Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.2.1. Private Hospital
8.2.2. Public Hospital
8.3. Online Retail
8.3.1. General E-Commerce
8.3.2. Specialty E-Commerce
8.4. Retail Pharmacy
8.4.1. Chain Pharmacy
8.4.2. Independent Pharmacy
8.2. Hospital Pharmacy
8.2.1. Private Hospital
8.2.2. Public Hospital
8.3. Online Retail
8.3.1. General E-Commerce
8.3.2. Specialty E-Commerce
8.4. Retail Pharmacy
8.4.1. Chain Pharmacy
8.4.2. Independent Pharmacy
9. Anti-viral Nasal Spray Market, by Prescription Status
9.1. Introduction
9.2. Over-The-Counter
9.3. Prescription
9.2. Over-The-Counter
9.3. Prescription
10. Anti-viral Nasal Spray Market, by End User
10.1. Introduction
10.2. Clinic
10.2.1. Primary Care Clinic
10.2.2. Specialty Clinic
10.3. Homecare
10.3.1. Adult Homecare
10.3.2. Pediatric Homecare
10.4. Hospital
10.4.1. Private Hospital
10.4.2. Public Hospital
10.2. Clinic
10.2.1. Primary Care Clinic
10.2.2. Specialty Clinic
10.3. Homecare
10.3.1. Adult Homecare
10.3.2. Pediatric Homecare
10.4. Hospital
10.4.1. Private Hospital
10.4.2. Public Hospital
11. Anti-viral Nasal Spray Market, by Age Group
11.1. Introduction
11.2. Adult
11.2.1. 18 to 45
11.2.2. Above 45
11.3. Pediatric
11.3.1. 0 to 12
11.3.2. 13 to 17
11.2. Adult
11.2.1. 18 to 45
11.2.2. Above 45
11.3. Pediatric
11.3.1. 0 to 12
11.3.2. 13 to 17
12. Americas Anti-viral Nasal Spray Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Anti-viral Nasal Spray Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Anti-viral Nasal Spray Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. SaNOtize Research & Development Corp.
15.3.2. Xlear, Inc.
15.3.3. Enzymatica AB
15.3.4. 3M Company
15.3.5. Marinomed Biotech AG
15.3.6. Ursapharm Arzneimittel GmbH
15.3.7. Riemser Arzneimittel AG
15.3.8. The Himalaya Drug Company
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. SaNOtize Research & Development Corp.
15.3.2. Xlear, Inc.
15.3.3. Enzymatica AB
15.3.4. 3M Company
15.3.5. Marinomed Biotech AG
15.3.6. Ursapharm Arzneimittel GmbH
15.3.7. Riemser Arzneimittel AG
15.3.8. The Himalaya Drug Company
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANTI-VIRAL NASAL SPRAY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ANTI-VIRAL NASAL SPRAY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ANTI-VIRAL NASAL SPRAY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ANTI-VIRAL NASAL SPRAY MARKET: RESEARCHAI
FIGURE 24. ANTI-VIRAL NASAL SPRAY MARKET: RESEARCHSTATISTICS
FIGURE 25. ANTI-VIRAL NASAL SPRAY MARKET: RESEARCHCONTACTS
FIGURE 26. ANTI-VIRAL NASAL SPRAY MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ANTI-VIRAL NASAL SPRAY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ANTI-VIRAL NASAL SPRAY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ANTI-VIRAL NASAL SPRAY MARKET: RESEARCHAI
FIGURE 24. ANTI-VIRAL NASAL SPRAY MARKET: RESEARCHSTATISTICS
FIGURE 25. ANTI-VIRAL NASAL SPRAY MARKET: RESEARCHCONTACTS
FIGURE 26. ANTI-VIRAL NASAL SPRAY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTI-VIRAL NASAL SPRAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY GENERAL E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY GENERAL E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY SPECIALTY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY SPECIALTY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIMARY CARE CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIMARY CARE CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 18 TO 45, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 18 TO 45, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ABOVE 45, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ABOVE 45, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 0 TO 12, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 0 TO 12, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 13 TO 17, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 13 TO 17, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 140. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 141. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 142. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 143. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 146. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 147. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 150. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 151. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 152. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 153. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 154. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 155. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 156. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 157. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 158. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 159. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 160. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 288. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 289. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 293. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 296. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 297. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 299. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 300. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 301. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 302. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 303. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 304. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 305. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 306. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 310. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 311. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 312. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 313. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 314. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 315. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 316. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 317. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 320. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 321. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 322. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 323. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 324. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 325. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 326. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 327. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 328. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 329. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 330. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 33
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY GENERAL E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY GENERAL E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY SPECIALTY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY SPECIALTY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIMARY CARE CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIMARY CARE CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 18 TO 45, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 18 TO 45, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ABOVE 45, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ABOVE 45, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 0 TO 12, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 0 TO 12, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 13 TO 17, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY 13 TO 17, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 140. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 141. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 142. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 143. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 146. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 147. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 150. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 151. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 152. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 153. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 154. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 155. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 156. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 157. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 158. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 159. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 160. CANADA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 288. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 289. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 293. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 296. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 297. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 299. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 300. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 301. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 302. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 303. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 304. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 305. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 306. GERMANY ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 310. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 311. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 312. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 313. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 314. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 315. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2024 (USD MILLION)
TABLE 316. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PRESCRIPTION STATUS, 2025-2030 (USD MILLION)
TABLE 317. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 320. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 321. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 322. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 323. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 324. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 325. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 326. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 327. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 328. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 329. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 330. FRANCE ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA ANTI-VIRAL NASAL SPRAY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 33
Samples
LOADING...
Companies Mentioned
The companies profiled in this Anti-viral Nasal Spray market report include:- SaNOtize Research & Development Corp.
- Xlear, Inc.
- Enzymatica AB
- 3M Company
- Marinomed Biotech AG
- Ursapharm Arzneimittel GmbH
- Riemser Arzneimittel AG
- The Himalaya Drug Company
